Blog

Jul 10

Planning for Clinical Adoption and Implementation of New Pediatric Health Technology

The Quadruple Aim[1] describes population health goals including decreasing costs, improving the patient experience, improving patient clinical outcomes, and improving the experience of providing care. Implementing new technologies into the current healthcare delivery system remains challenging and the Quadruple Aim goals play a role in the successful clinical adoption of... read more →
Mar 21
Jan 16

New England Pediatric Device Consortium Provides Seed Funding to Four Companies

New England Pediatric Device Consortium (NEPDC) is pleased to announce four recipients of the organization’s latest round of seed awards. Recipients of Pre-Seed funding and in-kind service support include PathMaker Neurosystems, a bioelectronics medicine company developing the MyoAmplifierTM system, an advanced non-invasive platform that treats children with paralysis and muscle... read more →
  • January 16, 2018
  • News
Dec 20

Four Characteristics to Consider When Finding a Business Partner

Written by Scott Holson, NEPDC Project Leader and George Price, Lab Manager of the Duhaime Pediatric Neurosurgery Laboratory at Massachusetts General Hospital In many cases, the largest hurdles clinical innovators face when entering the medical device field involve the intangible constraints including time away from busy clinical schedules and a... read more →
Sep 26
Sep 08

NEPDC Funds Three Companies for Pediatric Healthcare Innovation

For a fourth year, NEPDC www.NEPDC.org has announced funding and in-kind service support for solutions targeting a specific need in pediatric healthcare. NEPDC opened a call for devices addressing unintended removal or dislodgment of catheters or tubing in early June 2017. "In the primary care setting, when I see families trying to manage long term health... read more →
  • September 8, 2017
  • News
Jun 26

June 2017 NEPDC Newsletter

In this issue: NEPDC Accepting Proposals for 2017 Target Challenge Grant Opportunity Pre-Seed Awards Announced Participants in IPI's Catalyst Program Develop Solutions for Unplanned Extubations in Babies and Children
Jun 21

LEO Pharma invests in Novopyxis

BALLERUP, Denmark and CAMBRIDGE, USA, 21 June 2017 - LEO Pharma announces an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical treatments in the skin. The hand-held aerosol device will be clinically tested on people with alopecia, where... read more →
  • June 21, 2017
  • News
Jun 06
Mar 31

March 2017 NEPDC Newsletter

In this issue: Integrating Industrial Design Resources into Early Product Planning Recent NEPDC Awardees Grant Deadline for next Pre-Seed opportunity is April 24, 2017